HMG-CoA reductase is a potential therapeutic target for migraine: a mendelian randomization study
Kang Qu, Mingxi Li, Peng Yu, Aarno Palotie, Alice Pressman, Andrea Carmine Belin, Anna Bjornsdottir, Arn M. J. M. van den Maagdenberg, Aster V. E. Harder, Bendik S. Winsvold, Bertram Müller−Myhsok, Bru Cormand, Caroline Ran, Carrie A. M. Northover, Christian Kubisch, Cornelia M. van Duijn, Dale R. Nyholt, Daniel I. Chasman, Daniëlle Posthuma, Davor Lessel, Dorret I. Boomsma, Eija Hämäläinen, Espen Saxhaug Kristoffersen, Ester Cuenca-León, George Davey Smith, Gisela M. Terwindt, Gudrun R. Sigurdardottir, Gyða Björnsdóttir, Heidi Hautakangas, Hreinn Stefánsson, Irene de Boer, Jaakko Kaprio, Jes Olesen, John‐Anker Zwart, Hreinn Stefánsson, Lannie Ligthart, Lenore J. Launer, Linda M. Pedersen, Lisette J. A. Kogelman, Lyn R. Griffiths, M. Arfan Ikram, Maija Wessman, Mari Kaunisto, Maria Gudlaug Hrafnsdottir, Marjo Hiekkala, Paul M Ridker, Martin Dichgans, Matti Pirinen, Mikko Kallela, Mitja Kurki, Mona Ameri Chalmer, Nancy L. Pedersen, Ólafur Sveinsson, Olli T. Raitakari, Padhraig Gormley, Patricia Pozo‐Rosich, Priit Palta, Rainer Malik, Risto Kajanne, Sigrid Børte, Sigurður H. Magnússon, Terho Lehtimäki, Thomas Hansen, Thorgeir E. Thorgeirsson, Tobias Freilinger, Tobias Kurth, Tõnu Esko, Verneri Anttila, Ville Artto, Baihua Wu, Miao Shi, Ming Dong (2024). HMG-CoA reductase is a potential therapeutic target for migraine: a mendelian randomization study. , 14(1), DOI: https://doi.org/10.1038/s41598-024-61628-9.
